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1  | INTRODUC TION
Imbalances of the oral microbiota, commonly referred to as mi-
crobial dysbiosis, have been associated with a wide range of oral 
diseases (Kilian et al., 2016). Most oral microbiota studies have fo-
cussed on plaque-induced diseases and have demonstrated a key 
role for dysbiosis in the pathophysiology of periodontitis and car-
ies. Clinically important changes of the structure of the microbiota 
are induced by a variety of environmental and host factors (Marsh, 
Head, & Devine, 2015) leading to the enrichment of species which 
for example are tolerant to an acidic environment in caries (Liu, 
Nascimento, & Burne, 2012), or subvert immune responses leading 
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Abstract
Objective: We investigated the relationship amongst the oral mucosal bacterial com-
munity, clinical severity and inflammatory markers in the two most common immune-
mediated oral mucosal diseases, namely recurrent aphthous stomatitis (RAS) and oral 
lichen planus (LP).
Methods: Patients with RAS (n = 15) and LP (n = 18) and healthy controls (n = 13) 
were recruited using criteria to reduce the effect of factors that influence the micro-
biota structure independently of oral mucosal disease. Clinical severity was quanti-
fied using validated scoring methods. DNA was extracted from oral mucosal swabs 
for 16S rRNA gene high-throughput sequencing. Salivary cytokines were measured 
using cytometric bead assays. Correlation studies were conducted amongst microbial 
diversity, clinical scores and cytokine concentrations.
Results: We observed a significant reduction of bacterial diversity in LP and RAS pa-
tients compared to controls (p = .021 and .044, respectively). Reduced bacterial di-
versity in LP and RAS correlated with increased clinical scores of the two conditions 
(⍴ = −0.551 to −0.714). A negative correlation was observed between microbial diver-
sity and salivary interferon-γ, interleukin-17A and interleukin-1β (⍴ = −0.325 to −0.449).
Conclusions: This study reports reduced oral microbial diversity in the context of 
increased mucosal inflammation and supports the role for microbial diversity as a 
marker or contributor to oral mucosal inflammatory disease activity and development.
K E Y W O R D S
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to destructive inflammation of the periodontium (Darveau, 2010). In 
addition, low-abundance pathogens themselves can cause microbi-
ota imbalances which in turn induce inflammatory responses in peri-
odontitis (Hajishengallis et al., 2011).
The role of microbial dysbiosis in oral disease may be not confined 
to plaque-induced oral diseases where the role of microbial biofilms has 
been long established. A number of studies have reported enrichment 
or depletion of specific bacterial genera and species in oral samples 
from patients suffering from immune-mediated oral mucosal diseases, 
such as recurrent aphthous stomatitis (RAS) (Bankvall et al., 2014; 
Hijazi et al., 2015; Kim et al., 2016; Marchini, Campos, Silva, Paulino, 
& Nobrega, 2007; Seoudi, Bergmeier, Drobniewski, Paster, & Fortune, 
2015) and oral lichen planus (LP) (Choi et al., 2016; Kazanowska-
Dygdała et al., 2016; Pankhurst, Auger, & Hardie, 1988; Wang et al., 
2016), for which historically the role of bacteria has been debated but 
never confirmed. Oral mucosal diseases, such as RAS and LP, have a 
proven negative impact on patient quality of life (Hegarty, McGrath, 
Hodgson, & Porter, 2002; Liu, Xiao, He, & Jiang, 2012), but with lit-
tle knowledge of the events at the mucosal interface that initiate and 
sustain inflammation, the treatment of these conditions remains un-
targeted and often ineffective (Belenguer-Guallar, Jimenez-Soriano, & 
Claramunt-Lozano, 2014).
A range of bacterial species including Streptococcus species 
and Helicobacter pylori were historically implicated in RAS (Hasan 
et al., 1995; Riggio, Lennon, & Wray, 2000), but their role has remained 
controversial. More recently, case–control studies of the oral micro-
biota have reported significant enrichment of other species (Rothia 
dentocariosa and Acinetobacter johnsonii) as well as decreased abun-
dance of Streptococcus salivarius, Neisseria and Veillonella species in 
patients suffering from RAS compared to controls (Kim et al., 2016; 
Seoudi et al., 2015). Equally, comparative analyses of mucosal and sali-
vary samples from patients suffering from oral LP and healthy controls 
have shown a positive association with periodontal disease-related 
species as well as decreased abundance of Streptococcus, Haemophilus, 
Corynebacterium, Cellulosimicrobium and Campylobacter (Choi et al., 
2016; Wang et al., 2016). While the cause–effect relationship between 
these species and the disease is yet to be elucidated, it has been long 
known that patients suffering from immune-mediated oral mucosal 
disease can respond well to a range of broad-spectrum anti-microbials 
(Ranganath & Pai, 2016). For example, chlorhexidine and tetracyclines 
are formally recommended for routine management of mild forms of 
mucosal ulceration related to RAS and LP (Pemberton, 2014) but there 
is no knowledge of specific microbial events underpinning the anti-in-
flammatory effect of these agents. Nonetheless, the positive effect of 
anti-microbials on the course of RAS and LP, coupled with findings of 
microbiota association studies, suggests that microbial involvement in 
the aetiology and pathogenesis of these conditions is very plausible, 
notwithstanding their complex pathophysiology which cannot be as-
cribed to a single pathogen.
In this study, we sought to study the relationship between 
the structure of the oral bacterial community and clinical disease 
severity of patients suffering from LP and RAS. We also investi-
gated the correlation of oral bacterial diversity and salivary levels 
of Th1, Th2 and Th17 inflammatory cytokines implicated in LP and 
RAS.
2  | MATERIAL S AND METHODS
2.1 | Ethics statement
Ethical approval for involvement of patients in this study was 
granted by North of Scotland Research Ethics Service (reference 
12/NS/0006). Written informed consent was obtained from all par-
ticipants according to the World Health Organization guidelines for 
Good Research Practice.
2.2 | Patient recruitment
Cases and controls were recruited at the Maxillofacial Unit of Aberdeen 
Royal Infirmary and the Institute of Dentistry of the University of 
Aberdeen, respectively, using stringent criteria as previously described 
(Hijazi et al., 2015) with some modifications. Full detail of the recruit-
ment methodology is reported in the Supporting information.
2.3 | Sample collection
Swabs of the lower left buccal sulcus were taken from participants 
in the morning before breakfast. Ulcerated areas were avoided to 
maintain consistency of sampled tissue type amongst the three 
groups. As such, the patients who presented with ulceration along 
the lower left buccal sulcus were sampled at the right lower buccal 
sulcus. Swabs were immersed in 500 µl of sodium phosphate (SP) 
buffer and the suspension was stored at 4°C for a maximum of 2 hr 
postcollection until DNA extraction was performed.
Whole unstimulated saliva samples (1.5 ml) were obtained over 
10 min under strictly controlled conditions as previously described 
(Navazesh, Kumar, & University of Southern California School of 
Dentistry, 2008) and snap-frozen for quantitation of cytokines. 
Another whole saliva sample (5 ml) was collected for Candida col-
ony quantitation which was carried out by sample concentration 
in 500 µl of fresh saline before serial ten-fold dilution plating onto 
Brilliance Candida Agar (Oxoid, Thermo Fisher Scientific). Plates 
were incubated at 37°C for 48 hr.
2.4 | DNA extraction and amplicon generation 
for sequencing
Genomic DNA was extracted from swabs using FastDNA SPIN 
Kit for soil (MP Biomedicals) following the manufacturer's instruc-
tions. Full detail of the DNA extraction protocol is reported in the 
Supporting information. To assess the bacterial diversity by 16S 
rRNA high-throughput sequencing, fusion primers consisting of 
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Illumina adapter overhang nucleotide sequences added to universal 
primers 27F and 338R were used to amplify the V1-V2 hypervari-
able regions of the 16S rRNA gene. Full detail of the PCR protocol is 
reported in the Supporting information.
2.5 | Library preparation and sequencing
The purified amplicons containing the Illumina overhang were in-
dexed with Illumina Nextera XT v2 indices (Illumina). Full detail of 
library preparation is reported in the Supporting information. The 
libraries were equimolar pooled and sequenced on an Illumina MiSeq 
Sequencing System using MiSeq v3 chemistry with 300 bp paired-
end reads. Base calling and FASTQ output files were generated 
by the MiSeq instrument. Sequences have been submitted to the 
BioSample database through Sequence Read Archive (Bioproject ID 
PRJNA609244).
Bioinformatic analyses are described in the Supporting 
information.
2.6 | Cytokine measurements
Frozen saliva samples were thawed on ice and centrifuged at 
6,000 g for 20 min. The supernatants were used for cytokine 
quantitation. Total protein in the saliva samples was quantified 
with the BCA protein assay kit (Pierce, Thermo Fisher Scientific) 
according to manufacturer's instructions. Concentrations of tu-
mour necrosis factor-α (TNF-α), interleukin-4 (IL-4), interleukin-6 
(IL-6), interleukin-10 (IL-10), interferon-γ (IFN-γ), interleukin-17A 
(IL-17A) and interleukin-1β (IL-1β) were measured using the BD 
CBA Human Enhanced Sensitivity Flex Sets (Catalog no. 561523, 
BD Biosciences) strictly according to manufacturer's instructions 
with no modifications. Clarified saliva supernatants (50 µl) and 
standards for each of the above cytokines (274–200,000 fg/ml) 
were added to prewashed antibody-coated plates. Capture Beads, 
Human Detection Reagent and the Enhanced Sensitivity Detection 
Reagent were sequentially incubated with samples and standards 
before acquisition. Sample and standard acquisition was carried 
out with the FACSCalibur flow cytometer (BD Biosciences), and 
output data analysed using the FCAP Array software, version 3 
(BD Biosciences).
2.7 | Statistical methods
Alpha diversity indexes (Shannon, Simpson's Index of Diversity, 
Chao1, phylogenetic diversity and number of observed OTUs) of 
the RAS and LP groups were compared to controls using Kruskal–
Wallis test with Dunn's multiple comparison test. Correlation matri-
ces reporting (a) alpha diversity indexes, (b) cytokine concentrations 
and (c) clinical severity scores of RAS and LP for each sample were 
designed. Correlation scores were calculated using Spearman's 
rank correlation, since values were mostly not normally distrib-
uted. Relative abundances of genera and species amongst different 
groups of samples were compared using the Kruskal–Wallis test with 
Benjamini–Hochberg correction for multiple testing; GraphPad Prism 
(v 8.3.0) and the pairs.panels function of the R package psych were 
used for statistics and figures. Cytokine concentrations amongst the 
three patient groups were compared by ANOVA with Dunn's post 
hoc test to allow multiple comparisons; graphs were created using 
SPSS. Two-sided statistical significance was set at p < .05.
3  | RESULTS
3.1 | Patient characteristics
Fifteen RAS patients (age (46.13 ± 11.84) years), 21 LP patients (age 
(50.17 ± 8.64) years) and 13 controls (age (48.62 ± 9.47) years) were re-
cruited with no significant difference in age distribution amongst the 
groups (p = .372). Three LP patients were subsequently excluded from 
the study as the respective samples did not meet sequencing qual-
ity control standards; thus, 18 LP patients were included in the study. 
Sex distribution was similar amongst the three groups of patients 
included in the study (11 female, seven male in the LP group; 10 fe-
male, five male in the RAS group; nine female, four male in the control 
group). Body mass index was between 20.56 and 29.98 with no sig-
nificant difference in BMI distribution amongst the groups (controls: 
24.31 ± 2.35, LP: 24.36 ± 2.17, RAS: 24.20 ± 2.21, p = .98). RAS disease 
scores were between 18 and 37. LP disease scores were between 9 
and 29. Whole unstimulated saliva flow values were between 0.32 and 
0.78 ml/min with no significant differences amongst the groups (con-
trols: 0.53 ± 0.11 ml/min, LP: 0.54 ± 0.13 ml/min, RAS: 0.50 ± 0.11 ml/
min, p = .62). Colony counts of Candida species cultured from whole 
saliva samples were between 14 and 624 CFU/ml. Key general and oral 
health characteristics of recruits included in the study are reported in 
Table S1.
3.2 | Composition and diversity of the oral 
mucosal bacterial community in oral mucosal disease 
patients and healthy controls
A total of 5,369,503 sequences (range 40,280–210,818, median 
128,058) from 43 samples were obtained after chimera filter-
ing and removal of low confidence OTUs (i.e. OTUs containing 
less than 122 sequences). These sequences were assigned to 537 
different OTUs, 14 (2.6%) of which were present in all samples. 
The genera present in all samples were as follows: Actinomyces, 
Alloprevotella, Atopobium, Capnocytophaga, Fusobacterium, Gemella, 
Granulicatella, Haemophilus, Leptotrichia, Porphyromonas, Prevotella, 
Rothia, Selenomonas, Streptococcus and Veillonella. Of those, the most 
abundant were Streptococcus, Haemophilus, Gemella, Veillonella and 
Prevotella. There were no statistical differences in the abundance of 
these genera amongst the three sample groups (Figure S1).
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Bacterial diversity was determined calculating the Shannon 
index and Simpson's Index of Diversity. Chao1 index, phyloge-
netic distance and number of observed OTUs, which are based 
on the presence/absence of a given species, were also calculated. 
Comparative analyses of the LP and RAS groups against the con-
trol group (Kruskal–Wallis non-parametric test) showed that the 
both had a significantly lower Chao1 index (p = .021 and p = .044 
for LP and RAS, respectively). All the other indices were comparable 
amongst the study groups (Figure 1).
Species- and genus-level abundance comparisons were made be-
tween each of the three pairings of sample groups (LP versus RAS; LP 
versus controls; RAS versus controls) against all species-level matches 
using the Kruskal–Wallis test followed by Benjamini–Hochberg cor-
rection for multiple testing. There was no significant difference in the 
abundance of any genus or species between cases and controls or 
amongst the three groups. Table S2 shows the abundance of individ-
ual genera and their prevalence in case and control samples. Principal 
component analyses undertaken on raw OTU abundance data showed 
no distinct group clustering within any samples group (Figure S2).
3.3 | Correlation of bacterial diversity and clinical 
severity of disease
The clinical severity score of individual RAS and LP patients was corre-
lated to the alpha diversity indices within each group using Spearman's 
rank correlation. An inverse correlation was found between the 
clinical severity and diversity indices. The correlation of RAS severity 
was significant with the Chao1 index (⍴ = −0.714, p = .008) and with 
the number of observed OTUs (⍴ = −0.601, p = .033). LP severity was 
significantly correlated with all five alpha diversity indices (Shannon's 
⍴ = −0.587, p = .015; Simpson's Index of Diversity ⍴ = −0.551, p = .024; 
phylogenetic distance ⍴ = −0.557, p = .022; Chao1 ⍴ = −0.624, p = .009; 
observed OTUs ⍴ = −0.636, p = .007) (Figure 2). This suggests that mu-
cosal microbial population diversity is reduced in active disease.
3.4 | Correlation of bacterial diversity and 
salivary cytokines
The concentration of TNF-α, IL-4, IL-6, IFN-γ, IL-10, IL-17A and 
IL-1β in whole saliva was measured using cytometric bead assays. 
Findings are presented as cytokine concentration absolute values in 
view of equal total protein concentrations in the three groups (con-
trols: 1675.16 ± 281.54 µg/ml, LP: 1646.05 ± 584.28 µg/ml, RAS: 
1,490.54 ± 1,028.34 µg/ml, p = .417). Concentrations of TNF-α, IL-4, 
IL-6, IL-17A and IL-1β in LP and RAS patients were significantly raised 
compared to the control group (Figure 3). IFN-γ was significantly raised 
in LP (p < .001) compared to RAS and controls while no statistically 
significant differences in IFN-γ levels were observed between the lat-
ter two groups (Figure 3). There were no significant differences in IL-10 
concentration amongst the three groups (data not shown).
Correlation studies of salivary cytokine concentration and bacte-
rial diversity values amongst all groups were carried out. As shown in 
F I G U R E  1   Alpha diversity amongst oral mucosal disease groups and controls. Boxes show the 25–75 percentile interval of data, and 
whiskers show the minimum and maximum ranges. Data from single patients are shown as black dots (RAS group), squares (LP group) or 
triangles (control group). Mean values for each index in each group are indicated by the symbol “+”. Boxes are colour-coded according to the 
group (dark grey: RAS; light grey: LP; white: control). Statistical significance was calculated for comparisons of the two disease groups versus 
controls using the Kruskal–Wallis test and is indicated by asterisks (*p < .05)
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Figure 4 there was a moderate to strong negative correlation of IFN-γ 
(⍴ = −0.449, 95% CI: −0.680 to −0.186, p = .003), IL-17A (⍴ = −0.401, 
95% CI: −0.616 to −0.134, p = .009) and IL-1β (⍴ = −0.418, 95% CI: 
−0.666 to −0.103, p = .007) concentrations with Chao1 values. A signif-
icant and direct correlation of IL-17A levels and clinical disease scores 
in both RAS and LP patients was observed (RAS: ⍴ = 0.58, 95% CI: 
0.5−0.85, p = .032; LP: ⍴ = 0.61, 95% CI: 0.17−0.85, p = .011) (Figure S3). 
Altogether, these findings (Figures 2 and 4) show that mucosal disease 
severity and inflammation, measured as concentration of salivary 
pro-inflammatory cytokines, correlate with reduced bacterial diversity.
4  | DISCUSSION
The study of oral microbiota-immunity interactions in the context 
of inflammatory oral mucosal diseases is critical to inform novel 
F I G U R E  2   Correlation plots of clinical severity scores and alpha diversity indices. Squares along the diagonal plane of the figure 
contain histograms showing data distribution for each value in the matrix (i.e. Shannon index, Simpson's Index of Diversity, phylogenetic 
diversity, Chao1 index, number of observed OTUs, RAS and LP severity scores). Scatter plots below the diagonal show coupled values of 
two different parameters for individual patients, and the line shows the linear fit calculated across all samples. Values above the diagonal 
show the Spearman ⍴ correlation and asterisks indicate p values (*p ≤ .05, **p ≤ .01, ***p ≤ .001). Each row/column shows values for the 
parameter indicated in the diagonal square. Scales on the sides of the external squares relate to the parameter in the same row/column of 
the corresponding diagonal square [Colour figure can be viewed at wileyonlinelibrary.com]
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therapeutic strategies beyond the current palliative options. In ad-
dition to the discovery of new treatment targets, our increased un-
derstanding of the relationship of the oral microbiota and immune 
responses driving oral mucosal diseases is important to identify 
markers of disease activity and thus monitor response to treatment.
There has been lack of consistency in the findings of microbiome 
studies of immune-mediated oral mucosal disease published to date 
(He et al., 2017; Hijazi et al., 2015; Kim et al., 2016; Seoudi et al., 
2015; Wang et al., 2016), and a microbial signature for LP and RAS 
patients has not been confirmed. Notwithstanding that a plethora of 
factors relating to the high-throughput sequencing approach may be 
explanatory of the inconsistent results, it is critical to reflect on the 
role of aspects relating to study design itself including recruitment 
strategy and sample collection. Although all studies have acknowl-
edged the limitation of small sample sizes, we suggest that small 
oral microbiota studies must adhere to stringent recruitment crite-
ria to minimise local and systemic factors known to influence the 
composition of the oral microbiota independently of immune-me-
diated mucosal disease, while larger studies may use regression 
models to adjust for these factors. In this study, patients with the 
range of host phenotypic characteristics known to influence the mi-
crobiome structure as reported by the Human Microbiome Project 
Consortium (Human Microbiome Project Consortium, 2012) were 
excluded, while ensuring equal distribution of age, sex, ethnicity 
and body mass index amongst the study groups. Patients were also 
screened for subclinical conditions, such as haematinic deficien-
cies, long known to affect the oral epithelial turnover (Challacombe, 
Barkhan, & Lehner, 1977) and likely to affect the structure of the oral 
mucosal microbiota. Further, control of local environmental factors 
was extended to regulation of sugar consumption levels and oral hy-
giene practices prior to sampling.
Host immunogenetics likely play a critical role in the pathogenesis 
of oral mucosal inflammatory disease as recently confirmed by a ge-
nome-wide association study which identified 97 genetic variants in-
dependently associated with recurrent aphthous stomatitis (Dudding 
et al., 2019). Future studies should investigate how these genetic vari-
ants relate to the structure of the oral microbiota.
The choice of sample site in oral microbiota studies also merits 
careful consideration. The composition of the microbiota in healthy 
individuals shows great diversity between different oral micro-en-
vironments with the subgingival environment displaying the great-
est level of diversity (Dewhirst et al., 2010), hence our consistent 
sampling approach and exclusion of patients presenting with gin-
gival inflammation, being it plaque-induced or not. Significant dif-
ferences in the composition of the oral microbiome between local 
mucosal samples and whole saliva have been confirmed in a recent 
study (Kragelund & Keller, 2019). It is reasonable to speculate that 
microbiome sampling from oral mucosa is more likely representa-
tive of the microbial community directly involved in mucosal inflam-
mation, while whole saliva samples capture the microbiota from 
the range of oral micro-environments, including those that play 
no role in immune-mediated mucosal disease, namely subgingival 
and hard tissue-associated microbiota. To maintain homogeneity 
of sampling substrate, analyses were limited to non-ulcerated mu-
cosa. Microbiota analysis of ulcerated oral mucosa by us and another 
group (Hijazi et al., 2015; Kim et al., 2016) has shown substantial 
F I G U R E  3   Concentration of salivary cytokines amongst oral mucosal disease groups and controls. Boxes show the 25–75 percentile 
interval of data, whiskers show the minimum and maximum values, and median values are represented as lines in the box. Boxes are 
coloured according to the group (dark grey: RAS; light grey: LP; white: control). Statistical significance was calculated by ANOVA with Dunn's 
post hoc test (*p ≤ .05, **p ≤ .01, ***p ≤ .001)
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phylum-level changes with decreased Firmicutes and increased 
Proteobacteria consistently with the well-established microbiota 
changes associated with bowel ulceration (Frank et al., 2007). This 
major shift in the microbiota populating the ulcerated mucosa is 
likely heavily influenced by the different tissue substrate (fibrin 
layer) replacing the breached epithelium at ulcerated mucosa and 
hence more likely to be an effect of the change of tissue substrate 
rather than a player in disease activity.
In the present study, composition differences of the bacterial com-
munity between controls and patients suffering from RAS or LP as-
cribable to individual species, as reported in previous studies, were not 
confirmed. The variance across individuals within each group, likely 
F I G U R E  4   Correlation plots of cytokine concentrations and Chao1 microbial diversity index. Squares in the diagonal plane contain 
histograms and density plots showing data distribution for each value in the matrix (i.e. Chao1 index, TNF-α, IL-4, IL-6, IL-10, IFN-ɣ, IL-17A, 
IL-1β). Scatter plots below the diagonal show coupled values of two different parameters for individual patients, and the line shows the linear 
fit calculated across all samples. Values above the diagonal indicate the Spearman ⍴ correlation and asterisks indicate P values (*p ≤ .05, 
**p ≤ .01, ***p ≤ .001). Each row/column shows values for the parameter indicated in the diagonal square. Scales on the sides of the external 
squares relate to the parameter in the same row/column of the corresponding diagonal square. IFN-ɣ, TNF-α and IL-4 concentrations are 
expressed as pg/ml of saliva, while IL-1β, IL-17A and IL-6 are expressed as fg/ml [Colour figure can be viewed at wileyonlinelibrary.com]
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reflective of the breath of disease activity, was larger than the in-
ter-group differences suggesting that considerably larger sample sizes 
may be required to identify species-level differences due to disease. 
Nonetheless, a significant overall reduction of bacterial taxonomic 
diversity in patients suffering from LP patients compared to controls 
was observed. This finding is in keeping with a previous report of re-
duced bacterial richness and diversity in erosive lichen planus (Wang 
et al., 2015). Reduced bacterial diversity compared to healthy controls 
has been reported in multi-system conditions characterised by recur-
rent oral ulceration, for example Behcet's disease (Coit et al., 2016).
For the first time, this study demonstrates a significant cor-
relation between the reduced bacterial diversity in LP and RAS 
(measured by a range of diversity indices) and disease activity quan-
tified using validated disease scores for LP and RAS. Both scores 
have previously shown sufficient sensitivity to detect response to 
treatment (Escudier et al., 2007; Tappuni, Kovacevic, Shirlaw, & 
Challacombe, 2013). The data here presented demonstrate an in-
verse correlation of the two scores with bacterial diversity paving 
the way for further studies of oral microbiome-based markers of dis-
ease activity. Both clinical scores were directly correlated with sali-
vary IL-17A. The correlation with the other inflammatory cytokines 
did not reach statistical significance. The important role of IL-17 in 
oral mucosal inflammation is supported by evidence of favourable 
response to the therapeutic targeting of IL-17 + T cells in recalcitrant 
erosive lichen planus (Solimani et al., 2019).
Correlation studies disclosed an inverse relationship between bac-
terial diversity and salivary concentrations of key Th1, Th2 and Th17 
inflammatory cytokines implicated separately in microbial dysbiosis 
(mostly in the gut) and oral mucosal inflammatory disease. A previ-
ous report showed a negative correlation of salivary IL-17 and bacte-
rial diversity in patients suffering from erosive lichen planus (Wang 
et al., 2015). This study shows a correlation of reduced bacterial diver-
sity with pro-inflammatory cytokines IFN-γ, IL-17A and IL-1β. There was 
no statistically significant correlation with TNF-α, the role of which has 
been long established in RAS (Sand & Thomsen, 2013) or IL-6 shown to 
be elevated in saliva of LP patients in a recent meta-analysis (Mozaffari, 
Sharifi, & Sadeghi, 2018). Future studies should extend analyses to 
other Th17-activating cytokines and inflammatory cytokines impli-
cated in immune conditions associated with oral mucosal disease such 
as IL-21 (Geri et al., 2011) as well as effector cytokines known to modify 
the composition of mucosal microbiota such as IL-22 (Korn et al., 2014).
Our findings of inflammatory cytokine-bacterial diversity cor-
relation studies support the suggestion that oral mucosal inflam-
mation provides a novel source of nutrients which result in major 
compositional changes of the microbiota (Marsh et al., 2015). On 
the other hand, it is plausible that imbalances of oral mucosal micro-
biota may themselves regulate mucosal inflammatory responses in 
line with current theories of host-microbiota interactions in the gut 
(Grigg & Sonnenberg, 2017). Indeed, repopulation of the oral cavity 
with a healthy microbiota has been proposed for the tackling of oral 
diseases (Zhang et al., 2018).
Future studies should also investigate the role of the oral my-
cobiome. In this study, the detection rate of Candida species and 
colony counts using standard culture methods were similar in the 
three groups and below clinically significant counts (Tooyama 
et al., 2015). Nonetheless, mycobiome analyses would be import-
ant to complement the data of this study in order to determine the 
role of fungal diversity in the modulation of oral mucosal inflam-
mation. A recent study has found reduced fungal diversity in LP 
patients compared to controls and correlations of a range of fungal 
genera with IL-17 (Li et al., 2019). Future studies should further 
investigate the clinical relevance of this finding and the relation-
ship with oral mucosal immune responses in the context of oral 
mucosal disease.
The correlation of reduced bacterial diversity with increased 
clinical scores and pro-inflammatory cytokines in saliva points to 
the potential value of oral microbiome diversity as marker of disease 
activity for control of immune-mediated oral mucosal diseases. We 
speculate that taxa-level changes underpinning reduced diversity 
in inflammation vary depending on disease activity. Future studies 
comprising larger groups of patients representing different stages 
of disease may disclose specific taxa-level changes that will aid the 
development of microbiota-targeted treatments.
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